A bleomycin/ifosfamide/cisplatin regimen exhibits poor activity against persistent or recurrent squamous gynecologic cancers

K. Behbakht, L. S. Massad, E. L. Yordan, S. H. Lincoln, J. A.H. Eriksson, L. Winkelman, K. DeGeest, C. Kirschner, G. D. Wilbanks

Research output: Contribution to journal › Article › peer-review